Dhruvi Pharma Private Limited, a amalgamated private limited company, was established on 16 July 2001 in Balanagar, Telangana, India. Engaging in medical equipment retail & distribution within the trade sector, it holds CIN: U24231TS2001PTC171830. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹9.65 Cr and a paid-up capital of ₹1.56 Cr.
It upholds a compliant status. Employing 375 professional, Its leadership includes Arvind Kumar Venkat (Nominee Director), Rupesh Hemendra Shah (Managing Director), Yashwant Singh (Nominee Director). Past directors included Arvind Kumar Venkat, Rupesh Hemendra Shah, Yashwant Singh. It holds no open charges and ₹57.75 Cr settled loans. Its latest AGM occurred on 01 September 2023, with the balance sheet filed on 31 March 2023. It is based at She No-2,7-2-1740, Fire Station Main Road Sanath Nagar, Balanagar, Telangana, 500018.
U24231TS2001PTC171830
171830
16 July 2001
₹9.65 Cr
₹1.56 Cr
Roc Hyderabad
Unlisted
Amalgamated
Explore comprehensive insights into Dhruvi Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arvind Kumar Venkat | Nominee Director | 09 Mar 2015 | Current |
| Rupesh Hemendra Shah | Managing Director | 16 Jul 2001 | Current |
| Yashwant Singh | Nominee Director | 03 Jul 2018 | Current |
| Deeptiben Rupeshbhai Shah | Director | 16 Jul 2001 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 26 Jun 2019 | Past |
| Pramod Abcsdd | Director | 09 Mar 2015 | Past |
| Pramod Abcsdd | Additional Director | 13 Jul 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dhruvi Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.17% increase. The company also saw a substantial fall in profitability, with a 34.94% decrease in profit. The company's net worth observed a substantial decline by a decrease of 16.63%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Dhruvi Pharma had a promoter holding of 30.00% and a public holding of 70.00%. The company had 4 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹577,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Sep 2016 | Hdfc Bank Limited | ₹1.00 Cr | Satisfied |
| 26 Feb 2015 | Hdfc Bank Limited | ₹50.00 Cr | Satisfied |
| 29 Sep 2011 | Yes Bank Limited | ₹5.25 Cr | Satisfied |
| 20 Nov 2007 | 3I Infotech Trusteeship Services Limited | ₹1.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Dhruvi Pharma has a workforce of 375 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Dhruvi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dhruvi Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Dhruvi Pharma Private Limited last Annual general meeting of members was held on 01 Sep 2023 as per latest MCA records. was documented.
Progress on A charge registered on 15 Sep 2016 via Charge ID 100067226 with Hdfc Bank Limited was fully satisfied on 03 Aug 2023. was documented.
The activity A charge registered on 26 Feb 2015 via Charge ID 10577115 with Hdfc Bank Limited was fully satisfied on 03 Aug 2023. was completed.
Dhruvi Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad. was recorded as a recent event.
A charge with Hdfc Bank Limited of Rs. 50.00 Cr registered on 26 Feb 2015 with Charge ID 10577115 was modified on 23 Dec 2022. was recorded as a recent event.
The activity Yashwant Singh was appointed as a Nominee Director was appointed as a Nominee Director on 03 Jul 2018 & has been associated with this company since 7 years 5 months . was completed.
The CIN of Dhruvi Pharma Private Limited is U24231TS2001PTC171830.
Dhruvi Pharma Private Limited is headquartered at She No-2,7-2-1740, Fire Station Main Road Sanath Nagar, Balanagar, Telangana, 500018.
Dhruvi Pharma Private Limited was incorporated on 16 July 2001.
The current directors of Dhruvi Pharma Private Limited are
The primary industry of Dhruvi Pharma Private Limited is Trade.
Dhruvi Pharma Private Limited is unlisted.
The authorized capital of Dhruvi Pharma Private Limited is ₹9.65 Cr, and the paid-up capital is ₹1.56 Cr.
The compliance status of Dhruvi Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX